 - link Copy URL
- [     Share on X ](https://twitter.com/intent/tweet?text=« Prix Hermès de l'innovation » for Novartis Access https://www.3blmedia.com/markdownify/node/72300?absolute=1&via=3blnews "Share on X")
- [  Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/72300?absolute=1 "Share on Linkedin")
- [  Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/72300?absolute=1 "Share on Facebook")
- [ email Share via email ](mailto:?subject=« Prix Hermès de l'innovation » for Novartis Access&body=ESG News from Novartis https://www.3blmedia.com/markdownify/node/72300?absolute=1 "Share via email")
 
 

 [Awards &amp; Rankings](/categories/awards-rankings)

 # « Prix Hermès de l'innovation » for Novartis Access

 


 

 Jul 4, 2016 1:10 PM ET

  Campaign:  [Novartis Access: Medicines to treat chronic diseases in lower-income countries ](/news/campaign/novartis-access-medicines-treat-chronic-diseases-lower-income-countries)  ![](https://3blcdn.com/styles/carousel_2x/s3/2026-08/Novartis_Access_1786917855.jpg "Juergen Brokatzky-Geiger (middle) collected the award during the official ceremony in Paris ")

 Juergen Brokatzky-Geiger (middle) collected the award during the official ceremony in Paris 

 

Novartis Access is the 2016 winner of the "Prix Hermès de l'innovation" in the category “Improvement of the human condition”. Jürgen Brokatzky-Geiger, Global Head Corporate Responsibility, collected the award during the official ceremony in Paris on June 14.

The "Prix Hermès de l'innovation" recognizes companies or organizations which have excelled in integrating the best state of knowledge into products and services offering more satisfaction to individuals and society. It is owned by the European Institute for Creative Strategies and Innovation.

Videos from the award ceremony:

- <https://vimeo.com/172499908>
- <https://vimeo.com/172509658>

Novartis Access includes 15 generic and patented medicines to address cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. The portfolio is offered to governments, NGOs and other public-sector healthcare providers in low and lower middle income countries for USD 1 per treatment, per month. The medicines in the portfolio have been selected based on their medical relevance: they are either on or pertain to a class included in the WHO Model List of Essential Medicines, or belong to the most frequently prescribed medicines in these disease areas. Novartis Access launched in Kenya in 2015 and we strive to reach 30 countries over the coming years depending on government and stakeholder demand.

Novartis Access is the latest addition to our company’s efforts to enhance access to healthcare for patients at every level of income. [www.novartisaccess.com](http://www.novartisaccess.com/)



 

### Additional Media

#### Images

 [  ![](https://3blcdn.com/styles/carousel_thumbnail_x2/s3/images/_MG_0692_0.jpg?h=7411a672)  Novartis Access is the latest addition to Novartis' efforts to enhance access to healthcare for patients at every level of income. ](https://3blcdn.com/images/_MG_0692_0.jpg "Novartis Access is the latest addition to Novartis' efforts to enhance access to healthcare for patients at every level of income.") 

 

 

 

 

 

 

 

 

 [![Novartis logo](/sites/default/files/Clients/novartis_logo_012919.jpg)](/profiles/novartis)

 

 

### More from Novartis

###### [Energize – A First-of-Its-Kind Program to Increase Access to Renewable Energy for Pharmaceutical Suppliers](/news/energize-first-its-kind-program-increase-access-renewable-energy-pharmaceutical-suppliers)

 Nov 4, 2021 6:00 AM ET

  



###### [Novartis and Medicines for Malaria Venture Report Positive Results for Phase 2b Study of Novel Ganaplacide/Lumefantrine Combination in Children With Malaria](/news/novartis-and-medicines-malaria-venture-report-positive-results-phase-2b-study-novel)

 Sep 29, 2021 3:00 PM ET

  



###### [Together Against Child Mortality: Novartis and Save the Children Launch Health Project in the Slums of Nairobi](/news/together-against-child-mortality-novartis-and-save-children-launch-health-project-slums)

 Aug 2, 2021 9:00 AM ET

  



###### [Novartis Pledges 10-year Commitment With Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and Other Leading Organizations to Co-create Effective, Measurable Solutions for Health Equity](/news/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges)

 Jul 20, 2021 8:15 AM ET

  



###### [Novartis and Hewlett Packard Enterprise Join Forces to Advance Novartis Global Health Efforts](/news/novartis-and-hewlett-packard-enterprise-join-forces-advance-novartis-global-health-efforts)

 Jun 23, 2021 12:10 PM ET

  



###### [Novartis Reaches Milestone Delivery of 1 Billion Courses of Antimalarial Treatment](/news/novartis-reaches-milestone-delivery-1-billion-courses-antimalarial-treatment)

 May 18, 2021 2:15 AM ET

  



###### [Novartis Inaugurates Innovative Watershed Project in India to Increase Water Availability](/news/novartis-inaugurates-innovative-watershed-project-india-increase-water-availability)

 Mar 22, 2021 10:30 AM ET

  



###### [Novartis and the Bill &amp; Melinda Gates Foundation Collaborate to Discover and Develop an Accessible in Vivo Gene Therapy for Sickle Cell Disease](/news/novartis-and-bill-melinda-gates-foundation-collaborate-discover-and-develop-accessible-vivo)

 Feb 17, 2021 1:15 AM ET